HCP
70
2
PFE
26
3
DAL
83
4
MCD
60
8
PPG
65
5
GME
70
4
MU
42
6
XYL
56
9
C
64
3
TROW
61
5
PDCO
46
8
CSX
64
4
BEN
50
4
KMX
70
6
HRL
48
6
NTRS
59
2
ITW
67
5
WHR
70
6
CVS
57
7
VRSK
80
3
HCP
70
2
PFE
26
3
DAL
83
4
MCD
60
8
PPG
65
5
GME
70
4
MU
42
6
XYL
56
9
C
64
3
TROW
61
5
PDCO
46
8
CSX
64
4
BEN
50
4
KMX
70
6
HRL
48
6
NTRS
59
2
ITW
67
5
WHR
70
6
CVS
57
7
VRSK
80
3
Financhill
Back

SPDR® S&P Pharmaceuticals ETF Vs. Range Cancer Therapeutics ETF Industry Stock Comparison

Buy
61

XPH
SPDR® S&P Pharmaceuticals ETF

Last Price:
45.80
Seasonality Move:
5.85%
Sell
50

CNCR
Range Cancer Therapeutics ETF

Last Price:
14.00
Seasonality Move:
2.55%
Buy
61
SPDR® S&P Pharmaceuticals ETF (XPH) is a Buy

Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?

  • The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $45.79. The Score for XPH is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • XPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $13.82. The Score for CNCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XPH Stock Price Chart

What is SPDR® S&P Pharmaceuticals ETF's stock price today?

  • The SPDR® S&P Pharmaceuticals ETF share price today is $45.79
    The current trend is moderately bearish and XPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $13.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight selling pressure.

XPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 47.61 Sell
Chaikin Money Flow: 8012 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.49 - 47.21) Sell
Bollinger Bands (100): (42.46 - 46.08) Buy

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 41.18 Sell
Chaikin Money Flow: -729 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.74 - 15.38) Sell
Bollinger Bands (100): (14.11 - 15.45) Sell

XPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.65 Buy
20-day SMA: 46.4 Sell
50-day SMA: 45.64 Buy
200-day SMA: 42.87 Buy
8-day EMA: 46.01 Sell
20-day EMA: 46.15 Sell
50-day EMA: 45.59 Buy
200-day EMA: 43.34 Buy

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.5 Buy
20-day SMA: 14.47 Sell
50-day SMA: 14.78 Sell
200-day SMA: 15.03 Sell
8-day EMA: 13.78 Buy
20-day EMA: 14.22 Sell
50-day EMA: 14.59 Sell
200-day EMA: 14.54 Sell

SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SPDR® S&P Pharmaceuticals ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):